Cellomatics Biosciences Wins Queen’s Award For EnterpriseGemma Cann2024-11-28T14:56:21+00:00April 21st, 2022|BioCity Nottingham, News|
Upperton Pharma Solutions Launches Nasal Delivery Development PlatformGemma Cann2022-06-30T11:32:23+01:00April 14th, 2022|News|
Life Science Start-Up Report 2022 Launched By Pioneer Group And JLLGemma Cann2024-11-28T14:07:46+00:00April 11th, 2022|Article, Investment|
AbbVie Partners With Pioneer Group To Launch The Golden Ticket ProgrammeGemma Cann2024-11-28T14:08:06+00:00April 6th, 2022|Accelerator, Article, Investment, News|
Invizius Awarded Major Biomedical Catalyst GrantGemma Cann2022-06-30T11:33:29+01:00April 1st, 2022|BioCity Glasgow, News|
Absolute Antibody Licenses Novel Fc Silencing Technology From mAbsolveGemma Cann2024-11-28T14:56:42+00:00March 31st, 2022|News, Wilton Centre|
Platelet Services Appoints Senior Research Scientist To Support GrowthGemma Cann2024-11-28T14:56:55+00:00March 30th, 2022|BioCity Nottingham, News|
4Degra Finalist For TCT Materials AwardGemma Cann2024-11-28T15:12:36+00:00March 29th, 2022|MediCity Nottingham, News|
GW Pharmaceuticals Begins Construction On 60,000sq ft Cannabis Facility At Kent Science ParkGemma Cann2024-11-28T15:12:51+00:00March 25th, 2022|Kent Science Park, News|
Cellomatics Strengthens Senior Management Team With Key AppointmentGemma Cann2024-11-28T15:13:09+00:00March 22nd, 2022|News|
